Health

Market access and evidence generation strategy

Our strategic services help clients to navigate uncertainties and maximise value throughout development and commercialisation of products.

We support commercial and development strategy, market access, and evidence generation, bringing together sector experts, experienced strategists and market leading analytics.

How the life sciences sector can address the greatest health challenges and reduce inequalities

Health is one of our most untapped opportunities for prosperity and happiness, as both individuals and society. Yet these opportunities are not shared equally. The life sciences sector has a unique opportunity to actively reduce health inequalities, which we explore in our report.

Explore the report
ONS Health Index Explorer

See the health index in your area, how it has changed over time and compares to other local authorities.

Start here
Going swimmingly or treading water?

Read our on point paper which explores whether the elective recovery plan is bringing down NHS waiting lists.

Read the report
NHS waiting list tracker

Explore our interactive tracker to see how waiting lists for NHS services vary across England.

Start here

We link global value strategies to local health system needs and priorities

At LCP Health Analytics, we recognise that securing access and reimbursement for novel therapies demands a strategic approach tailored to each product and market. Our dedicated market access team goes beyond generic consulting models to provide an integrated, bespoke service reflecting your specific needs for value demonstration, pricing strategy, and payer engagement. The team has experience from HTA success from over 300 submissions globally.

We foster early payer involvement through our global payer network for value demonstration, access and pricing, enabling successful launches. We quantify the full range of tangible and intangible value elements of your therapy to payers and health systems using real-world evidence. We also have extensive experience in co-creating innovative outcome-based agreements responsive to healthcare priorities.

With real-world analytics integral to our market access approach, we stand distinct from typical market access consultancies through linking global value strategies to local health system needs and priorities. Our goal is to help you achieve broad, rapid and sustainable patient access.

We support our clients across the following areas:

Market access strategy

Assessment of the pricing and reimbursement landscape
Payer research/advisory boards to understand decision-drivers
Value story/messaging
Environment shaping
Market access strategy/roadmap

Evidence generation strategy

Evidence gap analysis
Data source landscaping
Assessment of HTA/regulatory acceptability
Development of cross-functional, real-world evidence strategy across the lifecycle